Effect of mindfulness-based intervention on endurance performance under pressure and performance-relevant mental attributes, an interdisciplinary perspective : Protocol for a Mindfulness-Based Peak Performance (MBPP) trial
Copyright © 2023. Published by Elsevier Inc..
Performance under pressure is one of the primary features of competitive sports. Considering that increased competition levels are typically accompanied by elevated stress and anxiety, athletes' ability to cope with stress has gained even more importance in recent years. Accordingly, the current trial, entitled Mindfulness-based Peak Performance (MBPP), will take an interdisciplinary approach (e.g., sport psychology, sports training, and cognitive neuroscience), to more definitively examine whether a MBPP affects athletic performance under pressure and relevant mental attributes. This study is an 8-week, three-arm, randomized controlled trial (RCT). A total of 90 athletes, aged between 18 and 30 years will be recruited. Eligible participants will be randomly assigned into (1) an MBPP group, (2) a self-talk (ST) group, and (3) a wait-list control (WC) group. The MBPP and ST interventions consist of a 60-min session weekly for 8 weeks. Primary outcomes are endurance performance and performance-relevant mental attributes including behavior (i.e., stress response, emotion regulation, and engagement) and neurocognitive processes (e.g., attention, executive function, brain resting state), which will be assessed at baseline and post-intervention. Dispositional mindfulness and athletic psychological skills will be secondary outcomes, also assessed at baseline and post-intervention. The MBPP and ST are expected to improve performance under pressure, but MBPP is expected to show greater improvement than ST. Additionally, we expect the MBPP will improve the relevant mental attributes. The results from this trial might provide rigorous evidence and insight into MBI application in the sports context. ClinicalTrials.govregistration:NCT05612295.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:129 |
---|---|
Enthalten in: |
Contemporary clinical trials - 129(2023) vom: 01. Juni, Seite 107175 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chang, Yu-Kai [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical Trial Protocol |
---|
Anmerkungen: |
Date Completed 29.05.2023 Date Revised 01.06.2023 published: Print-Electronic ClinicalTrials.gov: NCT05612295 Citation Status MEDLINE |
---|
doi: |
10.1016/j.cct.2023.107175 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355331594 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM355331594 | ||
003 | DE-627 | ||
005 | 20231226064125.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cct.2023.107175 |2 doi | |
028 | 5 | 2 | |a pubmed24n1184.xml |
035 | |a (DE-627)NLM355331594 | ||
035 | |a (NLM)37028503 | ||
035 | |a (PII)S1551-7144(23)00098-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chang, Yu-Kai |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of mindfulness-based intervention on endurance performance under pressure and performance-relevant mental attributes, an interdisciplinary perspective |b Protocol for a Mindfulness-Based Peak Performance (MBPP) trial |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.05.2023 | ||
500 | |a Date Revised 01.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a ClinicalTrials.gov: NCT05612295 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
520 | |a Performance under pressure is one of the primary features of competitive sports. Considering that increased competition levels are typically accompanied by elevated stress and anxiety, athletes' ability to cope with stress has gained even more importance in recent years. Accordingly, the current trial, entitled Mindfulness-based Peak Performance (MBPP), will take an interdisciplinary approach (e.g., sport psychology, sports training, and cognitive neuroscience), to more definitively examine whether a MBPP affects athletic performance under pressure and relevant mental attributes. This study is an 8-week, three-arm, randomized controlled trial (RCT). A total of 90 athletes, aged between 18 and 30 years will be recruited. Eligible participants will be randomly assigned into (1) an MBPP group, (2) a self-talk (ST) group, and (3) a wait-list control (WC) group. The MBPP and ST interventions consist of a 60-min session weekly for 8 weeks. Primary outcomes are endurance performance and performance-relevant mental attributes including behavior (i.e., stress response, emotion regulation, and engagement) and neurocognitive processes (e.g., attention, executive function, brain resting state), which will be assessed at baseline and post-intervention. Dispositional mindfulness and athletic psychological skills will be secondary outcomes, also assessed at baseline and post-intervention. The MBPP and ST are expected to improve performance under pressure, but MBPP is expected to show greater improvement than ST. Additionally, we expect the MBPP will improve the relevant mental attributes. The results from this trial might provide rigorous evidence and insight into MBI application in the sports context. ClinicalTrials.govregistration:NCT05612295 | ||
650 | 4 | |a Clinical Trial Protocol | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Endurance performance | |
650 | 4 | |a Interdisciplinary approach | |
650 | 4 | |a Mental attributes | |
650 | 4 | |a Mindfulness-based intervention | |
650 | 4 | |a Performance under pressure | |
700 | 1 | |a Gill, Diane L |e verfasserin |4 aut | |
700 | 1 | |a Creswell, J David |e verfasserin |4 aut | |
700 | 1 | |a Chen, Dong-Tai |e verfasserin |4 aut | |
700 | 1 | |a Lin, Chi-Yen |e verfasserin |4 aut | |
700 | 1 | |a Chu, Chien-Heng |e verfasserin |4 aut | |
700 | 1 | |a Nien, Jui-Ti |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Contemporary clinical trials |d 2005 |g 129(2023) vom: 01. Juni, Seite 107175 |w (DE-627)NLM154869031 |x 1559-2030 |7 nnns |
773 | 1 | 8 | |g volume:129 |g year:2023 |g day:01 |g month:06 |g pages:107175 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cct.2023.107175 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 129 |j 2023 |b 01 |c 06 |h 107175 |